Skip to content

Repligen

US · RGEN #1445 by market cap Listed 1970
163.81 -6.48 -3.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Repligen

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Founded
1981
CEO
Mr. Olivier Loeillot
Employees
2,000
Headquarters
Waltham, Massachusetts, United States of America
Fiscal year end
12-31
Website
repligen.com

Company profile

Exchange
US
Symbol
RGEN
Market-cap rank
#1445
Listing date
1970-01-01
Market cap
10.47B
Float cap
9.99B
Shares out
63.92M
Float shares
60.96M

Sectors & themes

Medical Instruments & Supplies Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Repligen discussion 0 comments

Add a comment